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Using the normal adult rat hepatocytes, plated on rat tail collagen-coated ishes and fed a chemically defined medium, 
we demonstrate h re that ciprofibrate at 0.1 mM concentration, increases ignificantly the mRNA levels of fatty acyl-CoA 
oxidase, enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase bifunctional protein, and thiolase (the three enzymes 
of the &oxidation system), and causes peroxisome proliferation. Increase in mRNA levels of these genes was evident 
within 1 h and was maximal 24 h after the addition of ciprofibrate. In hepatocytes cultured in the absence. of ciprofibrate, 
the basal levels of these enzymes were low and further declined with time. Concomitant reatment of hepatocytes with 
cycloheximide did not inhibit or superinduce the mRNA levels, indicating that this induction may represent a primary 
(direct) effect of this compound on the expression of these genes and does not apparently involve short-lived repressor 
protein(s). 
Peroxisome proliferation; mRNA; Tissue culture; (Rat hepatocyte) 
1. INTRODUCTION 
An elucidation of the molecular mechanisms by 
which carcinogenic peroxisome proliferators 
regulate gene expression in liver is necessary for the 
understanding of the biological implications of 
peroxisome proliferation [ 1,2]. Using the cDNAs 
for the peroxisomal P-oxidation enzymes, it has 
been shown that the mRNA levels of the fl- 
oxidation genes increase 20- to 30-fold in the livers 
of rats treated with peroxisome proliferators 
[3-51. This increase has been attributed to enhanc- 
ed rates of transcription of the corresponding 
genes [5]. The mechanism by which structurally 
diverse peroxisome proliferators affect transcrip- 
tion of particular genes in a tissue-specific manner 
[2,5] has been postulated to involve binding of 
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these xenobiotics to specific recognition molecules 
in responsive cell types [2,6], in a manner 
analogous to the mechanism of action of estrogens 
[7] and 2,3,7,8-tetrachlorodibenzo-p-dioxin [8]. In 
this study we used primary cultures of rat 
hepatocytes to determine whether or not the perox- 
isome proliferator-induced increase in P-oxidation 
system mRNAs is a secondary response influenced 
by labile protein(s). We demonstrate here that 
ciprofibrate, a peroxisome proliferator, rapidly in- 
duces the accumulation of mRNAs of &oxidation 
system genes in cultured rat hepatocytes and that 
the induction occurs even in the presence of 
cycloheximide, an inhibitor of protein synthesis, 
indicating that it is a primary effect of ciprofibrate 
on liver cells. 
2. MATERIALS AND METHODS 
2.1. Hepatocyte cultures and treatment 
Normal adult male F344 rats (175-200 g) were used for the 
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Fig.1. Electron microscopic appearance of portions of rat hepatocytes in control (A) cultures and those treated with 0.1 mM 
ciprofibrate (B) for 5 days. Liver cells in A were processed for routine transmission electron microscopy, whereas the cells in B were 
processed for the cytochemical localization of catalase by alkaline diaminobenzidine. Increase in the number of peroxisomes (P) is 
evident in B. 
isolation of hepatocytes by in situ collagenase perfusion 191. 
The isolated hepatocytes were maintained in primary culture on 
rat-tail collagen-coated dishes and after attachment fed a 
chemically defined serum-free medium and 2% DMSO [lo]. 
The cells were maintained in this medium for at least 24-48 h 
prior to treatment with ciprofibrate and/or cycloheximide. 
Ciprofibrate was added to the culture medium at 0.05, 0.075, 
0.1, 0.5 or 1.0 mM concentrations and the medium changed 
once every 24 h. The cells were harvested after 2, 3 and 5 days 
of exposure to the drug and processed for electron microscopy. 
Selected samples were processed for cytochemical localization 
of peroxisomal catalase [l l] or for immunocytochemical l bel- 
ing of catalase and PBE by the protein-A gold method [12]. 
Changes in peroxisome volume and labeling densities were 
determined as described [12]. For the time dependence of induc- 
tion of mRNAs of the P-oxidation system, ciprofibrate was 
added to the culture medium at 0.1 mM concentration and cells 
were harvested for RNA extraction after 1,4, 8, 12 and 24 h ex- 
posure. To investigate the effect of inhibition of protein syn- 
thesis on ciprofibrate inducible P-oxidation mRNAs, 
hepatocytes were treated for 8 h with ciprofibrate (0.1 mM) in 
the presence and absence of cycloheximide (10 fig/ml). 
2.2. Isolation of RNA and blot hybridization 
Total cellular RNA from hepatocytes was extracted in 
guanidinium thiocyanate and analyzed by Northern and dot- 
blot hybridization as described 1131. 
3. RESULTS AND DISCUSSION 
Dose dependent increases in peroxisome number 
were observed in hepatocytes treated with 
ciprofibrate, but higher dose levels (0.5 and 
Fig.2. Immunocytochemical localization, by the protein-A gold method, of catalase (A and B) and PBE (C and D) in rat hepatocytes 
cultured in the absence (A and C) and presence of 0.1 mM ciprofibrate (B and D) for 3 days. 
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of this 
[ 141, than those employed previous- 
ly’ [15,16]. 
Northern blot analysis of RNA isolated from 
cells exposed to 0.1 mM ciprofibrate for l-24 h 
revealed that fatty acyl CoA oxidase (FAOxase) 
(fig.3A), PBE (fig.fB) and thiolase (THL) (not 
shown) mRNAs were induced by ciprofibrate in a 
time-dependent manner. The levels of these B- 
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oxidation mRNAs were increased within 4 h and 
reached a maximum at 12-24 h. By 24 h of 
ciprofibrate treatment he &oxidation mRNAs in- 
creased 7- to 26-fold compared to controls. In 
hepatocytes cultured in the absence of ciprofibrate 
the basal levels of mRNAs of all three ,&oxidation 
genes were low (THL < PBE < FAOXase) and fur- 
ther declined with time in culture. The catalase 
mRNA increase was <Zfold with ciprofibrate 
treatment during the 24 h exposure (not shown). 
No changes in albumin mRNA (fig.3C) levels were 
noted. Rapid increases in the levels of peroxisomal 
P-oxidation system mRNAs observed here in 
primary hepatocyte cultures exposed to 
ciprofibrate, are consistent with earlier reports of 
increases in vivo in the livers of rats given a single 
intragastric dose of structurally different perox- 
isome proliferators [5,13], and in hepatocytes 
cultured in the presence of nafenopin [ 171. In con- 
trast, Chatterjee et al. [18] noted a lo-15 h delay 
in the induction of PBE mRNA in rat hepatocytes 
exposed in vitro to Wy-14643. This discrepancy is 
most likely due to differences in culture condi- 
tions, since Wy-14643 caused a rapid induction in 
vivo of &oxidation system mRNAs in livers of rats 
beginning as early as 30 min after a single in- 
tragastric dose [ 131. 
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Fig.3. Northern blot analysis (10 fig total RNA/lane) of time-course of changes in the FAOxase (panel A), PBE (panel B) and albumin 
(panel C) mRNA levels in hepatocytes cultured in the absence (C) or presence (T) of 0.1 mM ciprofibrate for 1, 4, 8, 12 and 24 h. 
The mRNA sizes indicated are: FAOxase 3.8 kb, PBE 3.0 kb, and albumin 2.3 kb. 
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To investigate whether inhibition of protein syn- 
thesis abolishes the ciprofibrate-inducible increases 
in the levels of mRNAs of P-oxidation system 
genes, we treated hepatocytes for 8 h with 0.1 mM 
ciprofibrate in the presence of 10 pg/ml cyclohex- 
imide. At this concentration, although cyclohex- 
imide caused 93% inhibition of protein synthesis 
(data not presented), it did not interfere with 
ciprofibrate-induced FAOxase (figs 4A,5A), PBE 
(figs 4B,5B), THL (fig.SC) and catalase (fig.4C) 
mRNA accumulation. 
The mechanism by which peroxisome pro- 
liferators increase the expression of genes responsi- 
ble for the characteristic pleiotropic response is not 
known, but it may be mediated by specific binding 
protein(s) [2,6]. Evidence indicates that 
hepatocytes, irrespective of their location in the 
body, recognize and respond to peroxisome pro- 
liferators, thus exemplifying cell specific induction 
[2]. The results of in vivo and in vitro induction 
studies clearly show detectable increases in mRNA 
levels of &oxidation genes in hepatocytes within 
0.5-l h after exposure to peroxisome proliferators 
[5,17]. The induction of transcription of ,& 
oxidation genes in liver by ciprofibrate does not 
appear to require protein synthesis. Further, the 
inhibition of protein synthesis did not result in the 
superinduction of &oxidation system mRNA 
levels. It is of interest to note that inhibition of 
protein synthesis does not superinduce the 
Fig.4. Effect of inhibition of protein synthesis by cycloheximide. Rat hepatocytes maintained in culture were exposed for 8 h to 
0.1 mM ciprofibrate and/or 10 fig/ml cycloheximide. Total RNA (15 pg/lane) was used for this analysis. FAOxase (panel A); PBE 
(panel B); and catalase (panel C). Control (con); ciprofibrate (tip); ciprofibrate + cycloheximide (tip + cyc); cycloheximide (cyc). The 
mRNA sizes indicated are: FAOxase 3.8 kb, PBE 3.0 kb, and catalase 2.4 kb. The filter in panel B was stripped and stained with 2% 
methylene blue to indicate amount of RNA loaded (panel D). 
209 
Volume 250, number 2 FEBS LETTERS July 1989 
8 
s 
4 
a2 
0 
=1 
03 
Fig.5. Dot-blot analysis of the effect of inhibition of protein synthesis on the induction of peroxisomal &oxidation system mRNAs 
by ciprofibrate in rat hepatocytes in culture. Hepatocytes maintained in vitro were exposed to 0.1 mM ciprofibrate and/or 10 fig/ml 
cycloheximide for 8 h. Total RNA was purified, denatured with formaldehyde and applied to filters in the amounts indicated. Lanes: 
1, no ciprofibrate, no cycloheximide; 2, ciprofibrate; 3, ciprofibrate and cycloheximide; 4, cycloheximide. The filters were hybridized 
with “P-labeled cDNAs for FAOxase (A), PBE (B), THL (C) and albumin (D). 
transcription of certain estrogen responsive genes 
[19,20]. On the other hand, inhibition of protein 
synthesis enhances 2,3,7,8-tetrachlorodibenzo-p- 
dioxin mediated transcription of cytochrome 
PI-450 gene [21]. The results of the present study 
suggest that the action of the peroxisome pro- 
liferator and its postulated receptor is sufficient 
for maximal induction of the P-oxidation genes 
and that labile repressor protein(s) may not play a 
modulating role. Additional studies are needed to 
elucidate the mechanism by which peroxisome pro- 
liferators regulate this primary response. 
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